Medical treatment of uric acid urolithiasis

被引:0
|
作者
Normand, M. [1 ]
机构
[1] Hop Pr St Martin, Serv Nephrol, F-33600 Pessac, France
来源
PROGRES EN UROLOGIE | 2013年 / 23卷
关键词
Uric acid kidney stone; Metabolic syndrome; Potassium citrate; Urinary pH; URINARY PH; STONE; CITRATE; PREVALENCE;
D O I
10.1016/j.fpurol.2012.11.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of uric kidney stone increases regularly, due to its high correlation with obesity, HTA, metabolic syndrome, diabetes and elderly age. The surgical treatment of urolithiasis may not be always easy, and the lithotripsy has a very low efficiency. So, an appropriate medical prescription, with a good patient observance, is very effective regarding kidney stone dissolution as well as for recurrence prevention. The urinary pH is acidic, which is the main factor of lithogenesis. It must be corrected by the alkalization of the urines. The potassium citrate treatment is very efficient, and has low side effects. It must be prescribed diluted in 1.5 L of water, to be effective all over the day and to avoid gastro-intestinal disorders. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:F77 / F83
页数:7
相关论文
共 50 条
  • [21] International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis
    Zeng, Guohua
    Zhu, Wei
    Robertson, William G.
    Penniston, Kristina L.
    Smith, Daron
    Pozdzik, Agnieszka
    Tefik, Tzevat
    Prezioso, Domenico
    Pearle, Margaret S.
    Chew, Ben H.
    Veser, Julian
    Fiori, Cristian
    Deng, Yaoliang
    Straub, Michael
    Tuerk, Christian
    Semins, Michelle J.
    Wang, Kunjie
    Marangella, Martino
    Jia, Zhankui
    Zhang, Liyuan
    Ye, Zhangqun
    Tiselius, Hans-Goran
    Sarica, Kemal
    UROLITHIASIS, 2022, 51 (01)
  • [22] The association between serum uric acid levels and the cardiometabolic phenotype among healthcare workers of Tabriz University of Medical Sciences
    Somi, Mohammadhossein
    Frounchi, Negin
    Zakavi, Seyed Sina
    Ostadrahimi, Alireza
    Gilani, Neda
    Faramarzi, Elnaz
    Sanaie, Sarvin
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2025, 17 (01) : 40 - 48
  • [23] Uric acid metabolism in polycystic ovary syndrome
    Liu, Yan-Nan
    Luo, Hai
    Che, Xuan
    Peng, Hui
    Li, Ming
    Liu, Ke-Xuan
    CLINICA CHIMICA ACTA, 2021, 517 : 74 - 80
  • [24] Uric acid nephrolithiasis: A systemic metabolic disorder
    Wiederkehr M.R.
    Moe O.W.
    Clinical Reviews in Bone and Mineral Metabolism, 2011, 9 (3-4): : 207 - 217
  • [25] Uric Acid in Metabolic and Cerebrovascular Disorders: A Review
    Cortese, Francesca
    Scicchitano, Pietro
    Cortese, Anna M.
    Meliota, Giovanni
    Andriani, Andrea
    Truncellito, Luigi
    Calculli, Giacinto
    Giordano, Paola
    Ciccone, Marco M.
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (06) : 610 - 618
  • [26] Uric acid and the kidney
    Sahar A. Fathallah-Shaykh
    Monica T. Cramer
    Pediatric Nephrology, 2014, 29 : 999 - 1008
  • [27] Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis
    Ng, Derry Minyao
    Hateem, Maria
    Mamuchashvi, Anny
    Wang, Kai-yun
    Pan, Jin-Feng
    Cheng, Yue
    Ma, Qi
    THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
  • [29] Uric acid and hypertension
    Schachter, M
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (32) : 4139 - 4143
  • [30] Uric acid and the kidney
    Fathallah-Shaykh, Sahar A.
    Cramer, Monica T.
    PEDIATRIC NEPHROLOGY, 2014, 29 (06) : 999 - 1008